AWARD WINNING PRESENTATION at ESCCA 2023

Download the full presentation Our own CTO, Lei Chen, held an award winning presentation at ESCCA 2023 in Utrecht, “Ultra-sensitive molecular MRD on flow cytometer using superRCA mutation assay”. In the presentation you can see results of testing AML patients using FCM, NGS, ddPCR and Rarity Biosciences ultra-sensitive superRCA. The presentation also suggests why Flow-MRD and superRCA molecular-MRD […]

Rarity Bioscience nominated for ESCCA Best Abstract Award

Read the full abstract here We are thrilled to share that Rarity Bioscience together with Karolinska Institutet and Uppsala University are nominated to the ESCCA Best Abstract Award, for the abstract “Ultra-sensitive molecular MRD on flow cytometer using superRCA mutation assay.”. A spart of that we have been awarded a plenary session presentation. Come and […]

Multiplex KRAS superRCA assays

Rarity offers ultra-sensitive and multiplexed mutation detection on 21 of the most common KRAS hotspot mutations for liquid biopsy research. To see our Multiplex KRAS superRCA assays, and explore all our assays: Explore assays Analyzing KRAS mutations in cancer is crucial for understanding the underlying mechanisms of tumor growth. These mutations, prevalent in cancers like […]

Rarity Bioscience Achieves ISO 13485 Quality System Certification

We can now proudly announce that Rarity Bioscience have achieved the ISO 13485:2016 certification from BSI! The achievement emphasizes Rarity Bioscience’s commitment to becoming a trusted and reliable partner in research, diagnostics, and therapeutics. Attaining this certification sets Rarity Bioscience apart from other early stage biotech startups in the rapidly evolving field of diagnostics. “This certification […]